Month: October 2020

…read more […]

Yahoo Finance’s Emily McCormick joins The First Trade with Alexis Christoforous and Brian Sozzi to discuss the latest quarterly earnings reports from 3M, Caterpillar and JetBlue. …read more […]

…read more […]

Yahoo Finance’s Alexis Christoforous, Brian Sozzi, and Jared Blikre discuss AMD buying rival chipmaker Xilinx in an all-stock deal. …read more […]

For a day that marked Tesla’s (TSLA) fifth straight quarter of reporting positive profits, last week’s 0.7% increase in the share price of Tesla stock seemed somewhat underwhelming.Reporting earnings Wednesday night, Tesla closed trading Thursday up only modestly, and really, only barely outperforming the S&P 500’s overall 0.5% move. Tesla called Q3 its “best quarter in history,” with pro forma earnings coming in 36% ahead of expectations at $0.76 per share, sales of $8.8 billion about 6% better than predicted, and free cash flowing strongly — $1.9 billion over the past 12 months.Tesla told investors Wednesday that it remains on …read more […]

(Bloomberg) — Harley-Davidson Inc. shares jumped as much as 13% in premarket trading on better-than-expected profit as Chief Executive Officer Jochen Zeitz’s moves to cut costs and boost margins on a smaller revenue base paid off in the third quarter.The Milwaukee, Wisconsin-based manufacturer reported adjusted earnings per share of $1.05, beating analysts’ consensus 29 cents. In line with Zeitz’s strategy of shrinking supply and shoring up pricing, the company said dealer inventory fell more than 30% compared with a year ago, and it was able to charge asking price for 2020 model year motorcycles in the quarter.Harley shares rose as …read more […]

When we invest, we’re generally looking for stocks that outperform the market average. Buying under-rated businesses… …read more […]

Pfizer said in a presentation that the independent monitor which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet. Chief Executive Albert Bourla has previously said the company could release data on whether or not the vaccine works as early as this month. U.S. President Donald Trump had said a vaccine could be available before the Nov. 3 election, but in recent weeks his administration has emphasized that one will be ready this year. …read more […]

Cristan Blackman’s Empirical Capital Partners is a Tennessee-based hedge fund founded in 2000 that takes a small number of concentrated positions in high-quality companies, with the fund investing the bulk of its assets in those companies which it sees as having the greatest potential for near-term gains. The fund managed a 13F portfolio containing $70.1 […] …read more […]

Multi-center trial to assess the safety and efficacy of pelareorep-atezolizumab combination therapies across multiple GI cancer indicationsTreatment aimed at 4.8M global GI cancer cases annually1 and the approximately 80% of GI cancer patients who do not respond to immune checkpoint inhibitor therapy currentlyStudy builds on prior early findings of greater than 90% clinical benefit in colorectal and greater than 80% increase in progression-free survival in pancreatic cancer patientsSAN DIEGO, CA and CALGARY, AB, Oct. …read more […]

Merck said it now expects full-year adjusted profit of between $5.91 and $6.01 per share, compared with its prior forecast of between $5.63 to $5.78 per share. For 2020, Merck now expects an unfavorable impact to revenue of about $2.35 billion due to the pandemic, up from $1.95 billion it had initially estimated. Excluding items, Merck earned $1.74 per share, beating analysts’ average estimates of $1.44 per share, according to IBES data from Refinitiv. …read more […]

Pfizer’s CEO Albert Bourla has said the company could release data on whether or not the vaccine works as early as this month, but the company said in a presentation that the independent data monitoring board which will determine whether or not the trial has been successful has not conducted any interim efficacy analyses yet. U.S. President Donald Trump had said a vaccine could be available before the Nov. 3 election, but in recent weeks his administration has emphasized that one will be ready this year. Pfizer hopes to be the first U.S. drugmaker to unveil successful data …read more […]

…read more […]